Lehetoség a magzati teratogén kockázat konkretizálására: Hat terhes isotretinoinkezelé sének értékelése

Translated title of the contribution: A chance to concretize the teratogenic risk: Healthy babies born to mother with isotretinoin treatment during pregnancy

Timmermann Gábor, Kondér Béla, Gidai János, E. Czeizel

Research output: Contribution to journalArticle

Abstract

The teratogenic risk means the probability of the occurrence of congenital abnormalities in fetuses after the exposure of teratogenic agents, mainly drugs during pregnancy. The recent highresolution ultrasound scanning may help us to concretize this teratogenic risk. The Genetic, Teratogenic and Family Planning Counseling Clinic of the authors in Budapest were visited by 10,557 couples or client between 1998 and 2007. Ten pregnant women visited this Clinic due to the isotretinoin (Roaccutan) treatment during pregnancy during the 10 years study period. At present Roaccutan is the most teratogenic drug among the medicinal products in Hungary because its teratogenic risk is 25% for a characteristic pattern of congenital abnormality syndrome including a/microtia, ventriculomegaly and contruncal cardiovascular malformation. These fetal defects are detectable by the high-resolution ultrasound scanning between 18th and 20th gestational week of pregnant women. Thus this examination was recommended for the 10 pregnant women with unintended use of isotretinoin (Roaccutan) in early pregnancy. Six pregnant women followed our advice and the repeated ultrasound scanning was not able to detect the above-mentioned characteristic defects and all the 6 newborns were healthy after birth. In conclusion the recent highresolution ultrasound examination provides a chance for the diagnosis of certain fetal defect between 18th and 20th gestational week of pregnant women. The Hungarian law allows these pregnant women to decide the termination of pregnancy until 20th (24th) gestational week after the diagnosis of severe fetal defects. However, this approach can protect the life of the major part of fetuses in pregnant women at high risk.

Original languageHungarian
Pages (from-to)513-517
Number of pages5
JournalLege Artis Medicinae
Volume20
Issue number8
Publication statusPublished - Aug 2010

Fingerprint

Isotretinoin
Pregnant Women
Mothers
Pregnancy
Therapeutics
Fetus
Hungary
Family Planning Services
Pharmaceutical Preparations
Counseling
Parturition
Newborn Infant

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lehetoség a magzati teratogén kockázat konkretizálására : Hat terhes isotretinoinkezelé sének értékelése. / Gábor, Timmermann; Béla, Kondér; János, Gidai; Czeizel, E.

In: Lege Artis Medicinae, Vol. 20, No. 8, 08.2010, p. 513-517.

Research output: Contribution to journalArticle

@article{0ba7dd23388e4070b0b633978d493c62,
title = "Lehetos{\'e}g a magzati teratog{\'e}n kock{\'a}zat konkretiz{\'a}l{\'a}s{\'a}ra: Hat terhes isotretinoinkezel{\'e} s{\'e}nek {\'e}rt{\'e}kel{\'e}se",
abstract = "The teratogenic risk means the probability of the occurrence of congenital abnormalities in fetuses after the exposure of teratogenic agents, mainly drugs during pregnancy. The recent highresolution ultrasound scanning may help us to concretize this teratogenic risk. The Genetic, Teratogenic and Family Planning Counseling Clinic of the authors in Budapest were visited by 10,557 couples or client between 1998 and 2007. Ten pregnant women visited this Clinic due to the isotretinoin (Roaccutan) treatment during pregnancy during the 10 years study period. At present Roaccutan is the most teratogenic drug among the medicinal products in Hungary because its teratogenic risk is 25{\%} for a characteristic pattern of congenital abnormality syndrome including a/microtia, ventriculomegaly and contruncal cardiovascular malformation. These fetal defects are detectable by the high-resolution ultrasound scanning between 18th and 20th gestational week of pregnant women. Thus this examination was recommended for the 10 pregnant women with unintended use of isotretinoin (Roaccutan) in early pregnancy. Six pregnant women followed our advice and the repeated ultrasound scanning was not able to detect the above-mentioned characteristic defects and all the 6 newborns were healthy after birth. In conclusion the recent highresolution ultrasound examination provides a chance for the diagnosis of certain fetal defect between 18th and 20th gestational week of pregnant women. The Hungarian law allows these pregnant women to decide the termination of pregnancy until 20th (24th) gestational week after the diagnosis of severe fetal defects. However, this approach can protect the life of the major part of fetuses in pregnant women at high risk.",
keywords = "Characteristic pattern of defects in isotretinoin syndrome, High-resolution ultrasound scanning, Isotretinoin (Roaccutan), Prevention of unaffected fetuses, Teratogenic drugs",
author = "Timmermann G{\'a}bor and Kond{\'e}r B{\'e}la and Gidai J{\'a}nos and E. Czeizel",
year = "2010",
month = "8",
language = "Hungarian",
volume = "20",
pages = "513--517",
journal = "Lege Artis Medicinae",
issn = "0866-4811",
publisher = "Literatura Medica Publishing House",
number = "8",

}

TY - JOUR

T1 - Lehetoség a magzati teratogén kockázat konkretizálására

T2 - Hat terhes isotretinoinkezelé sének értékelése

AU - Gábor, Timmermann

AU - Béla, Kondér

AU - János, Gidai

AU - Czeizel, E.

PY - 2010/8

Y1 - 2010/8

N2 - The teratogenic risk means the probability of the occurrence of congenital abnormalities in fetuses after the exposure of teratogenic agents, mainly drugs during pregnancy. The recent highresolution ultrasound scanning may help us to concretize this teratogenic risk. The Genetic, Teratogenic and Family Planning Counseling Clinic of the authors in Budapest were visited by 10,557 couples or client between 1998 and 2007. Ten pregnant women visited this Clinic due to the isotretinoin (Roaccutan) treatment during pregnancy during the 10 years study period. At present Roaccutan is the most teratogenic drug among the medicinal products in Hungary because its teratogenic risk is 25% for a characteristic pattern of congenital abnormality syndrome including a/microtia, ventriculomegaly and contruncal cardiovascular malformation. These fetal defects are detectable by the high-resolution ultrasound scanning between 18th and 20th gestational week of pregnant women. Thus this examination was recommended for the 10 pregnant women with unintended use of isotretinoin (Roaccutan) in early pregnancy. Six pregnant women followed our advice and the repeated ultrasound scanning was not able to detect the above-mentioned characteristic defects and all the 6 newborns were healthy after birth. In conclusion the recent highresolution ultrasound examination provides a chance for the diagnosis of certain fetal defect between 18th and 20th gestational week of pregnant women. The Hungarian law allows these pregnant women to decide the termination of pregnancy until 20th (24th) gestational week after the diagnosis of severe fetal defects. However, this approach can protect the life of the major part of fetuses in pregnant women at high risk.

AB - The teratogenic risk means the probability of the occurrence of congenital abnormalities in fetuses after the exposure of teratogenic agents, mainly drugs during pregnancy. The recent highresolution ultrasound scanning may help us to concretize this teratogenic risk. The Genetic, Teratogenic and Family Planning Counseling Clinic of the authors in Budapest were visited by 10,557 couples or client between 1998 and 2007. Ten pregnant women visited this Clinic due to the isotretinoin (Roaccutan) treatment during pregnancy during the 10 years study period. At present Roaccutan is the most teratogenic drug among the medicinal products in Hungary because its teratogenic risk is 25% for a characteristic pattern of congenital abnormality syndrome including a/microtia, ventriculomegaly and contruncal cardiovascular malformation. These fetal defects are detectable by the high-resolution ultrasound scanning between 18th and 20th gestational week of pregnant women. Thus this examination was recommended for the 10 pregnant women with unintended use of isotretinoin (Roaccutan) in early pregnancy. Six pregnant women followed our advice and the repeated ultrasound scanning was not able to detect the above-mentioned characteristic defects and all the 6 newborns were healthy after birth. In conclusion the recent highresolution ultrasound examination provides a chance for the diagnosis of certain fetal defect between 18th and 20th gestational week of pregnant women. The Hungarian law allows these pregnant women to decide the termination of pregnancy until 20th (24th) gestational week after the diagnosis of severe fetal defects. However, this approach can protect the life of the major part of fetuses in pregnant women at high risk.

KW - Characteristic pattern of defects in isotretinoin syndrome

KW - High-resolution ultrasound scanning

KW - Isotretinoin (Roaccutan)

KW - Prevention of unaffected fetuses

KW - Teratogenic drugs

UR - http://www.scopus.com/inward/record.url?scp=77956725204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956725204&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77956725204

VL - 20

SP - 513

EP - 517

JO - Lege Artis Medicinae

JF - Lege Artis Medicinae

SN - 0866-4811

IS - 8

ER -